Pharma

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

GlaxoSmithKline said its Asia Pacific sales could double in the next five years as growing wealth boosts demands for better healthcare and as it cuts prices in some Asian countries. "Clearly there will be a very high demand in the future because the economic development of the countries in the region and people want more healthcare," Christophe Weber, GSK Asia Pacific chief, told Reuters.

Today in Research & Development...keeping you current

Cerner Enters R&D Pact with University
HealthDataManagement, 12/08/09

ARIAD Presents Positive Clinical Proof-of-Concept Data on AP24534 in Drug-Resistant Hematological Cancers at ASH Annual Meeting
ARIAD Pharmaceuticals, 12/08/09

Facet Biotech and Bristol-Myers Squibb Report Promising Phase I/II Interim Data for Elotuzumab in Patients with Relapsed Multiple Myeloma
Bristol Myers-Squibb Company, 12/08/09